129 related articles for article (PubMed ID: 6027552)
1. Effective immunotherapy of Friend virus infection.
Chirigos MA; March RW; Hook W; Hoemann R
Proc Soc Exp Biol Med; 1967 May; 125(1):35-7. PubMed ID: 6027552
[No Abstract] [Full Text] [Related]
2. [Neutralization bioassay for Friend leukemia virus].
BasombrÃo MA; Genovese J
Medicina (B Aires); 1978; 38(3):245-9. PubMed ID: 692359
[No Abstract] [Full Text] [Related]
3. Formation of antibodies against salmonella lipopolysaccharides during a latent infection by Friend murine leukemia virus.
Ransom JP; Gorman JM; Tulve S
Cancer Res; 1969 Jul; 29(7):1407-15. PubMed ID: 5799159
[No Abstract] [Full Text] [Related]
4. Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies.
Chesebro B; Wehrly K
J Exp Med; 1976 Jan; 143(1):73-84. PubMed ID: 1244422
[TBL] [Abstract][Full Text] [Related]
5. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
Steeves RA; Axelrad AA
Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
[No Abstract] [Full Text] [Related]
6. Suppression of established Friend virus leukemia by statolon. IV. Role of humoral antibody in the development of a dormant infection.
Wheelock EF; Toy ST; Caroline NL; Sibal LR; Fink MA; Beverley PC; Allison AC
J Natl Cancer Inst; 1972 Mar; 48(3):665-73. PubMed ID: 5062046
[No Abstract] [Full Text] [Related]
7. Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.
Wahren B
J Natl Cancer Inst; 1968 Oct; 41(4):931-8. PubMed ID: 5693664
[No Abstract] [Full Text] [Related]
8. Cellular antigen of Friend virus-induced leukemias.
Steeves RA
Cancer Res; 1968 Feb; 28(2):338-42. PubMed ID: 5644179
[No Abstract] [Full Text] [Related]
9. Genetic aspects of resistance to Friend leukemia virus.
Franker CK; Quilligan JJ
Proc Soc Exp Biol Med; 1966 Apr; 121(4):1090-3. PubMed ID: 5937708
[No Abstract] [Full Text] [Related]
10. Expression of virus-associated antigens and immune cell functions during spontaneous regression of the Friend viral murine leukemia.
Cerny J; Essex M; Rich MA; Hardy WD
Int J Cancer; 1975 Feb; 15(2):351-65. PubMed ID: 47847
[TBL] [Abstract][Full Text] [Related]
11. Role of Friend-associated lymphatic leukemia virus in immunization against Friend leukemia complex.
Bendinelli M
Experientia; 1977 Apr; 33(4):455-6. PubMed ID: 862726
[TBL] [Abstract][Full Text] [Related]
12. Effect of normal serum and antithymocyte serum on Friend disease in mice.
Larson CL; Ushijima RN; Baker RE; Baker MB; Gillespie CA
J Natl Cancer Inst; 1972 May; 48(5):1403-7. PubMed ID: 4337911
[No Abstract] [Full Text] [Related]
13. Immunotherapy of Friend disease in mice employing viable BCG vaccine.
Larson CL; Baker RE; Ushijima RN; Baker MB; Gillespie C
Proc Soc Exp Biol Med; 1972 Jun; 140(2):700-2. PubMed ID: 4556666
[No Abstract] [Full Text] [Related]
14. Prevention of friend virus leukemogenesis by concanavalin A. I. Detection of dormant virus and role of humoral antibody in protected mice.
Kateley JR; Friedman H
J Natl Cancer Inst; 1974 Jul; 53(1):151-8. PubMed ID: 4835102
[No Abstract] [Full Text] [Related]
15. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
McCoy JL; Fefer A; Glynn JP
Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
[No Abstract] [Full Text] [Related]
16. Reversible splenomegaly with low virus production induced in hyperimmune mice by parabiosis with Friend-virus-infected mice.
Takizawa K; Yoshikura H; Sugano H; Yamamoto T
Int J Cancer; 1973 Sep; 12(2):502-10. PubMed ID: 4799699
[No Abstract] [Full Text] [Related]
17. Enhancement of Friend virus leukemia by leucogenenol.
Elliott SC; Jacoby AN; Barnhill MA; Howard WE
J Natl Cancer Inst; 1973 Oct; 51(4):1135-9. PubMed ID: 4542842
[No Abstract] [Full Text] [Related]
18. Humoral and cellular immune responses in susceptible and resistant strains of mice infected with friend leukemia virus.
Ceglowski WS; Campbell BP; Mortensen RF; Friedman H
Proc Soc Exp Biol Med; 1974 Jun; 146(2):619-24. PubMed ID: 4599492
[No Abstract] [Full Text] [Related]
19. Passive and active immunity to Friend virus disease.
Mirand EA; Grace JT; Buffett RF
Nature; 1966 Feb; 209(5024):696-8. PubMed ID: 5922129
[No Abstract] [Full Text] [Related]
20. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
